Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leprosy in Mexico.

Rocio Ivette Lopez Roa1, Mary Fafutis Morris

  • 1Immunology and Dermatology Research Center, C.U.C.S, University of Guadalajara/Dermatologic Institute of Jalisco Av. Federalismo Nte #3102, 44220, Guadalajara Jalisco, Mexico. rockroa2000@yahoo.es

Nihon Hansenbyo Gakkai Zasshi = Japanese Journal of Leprosy : Official Organ of the Japanese Leprosy Association
|March 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Soluble Isoform of CD155 Is Elevated in Basal Cell Carcinoma.

The American Journal of dermatopathology·2024
Same author

<i>Lactobacillus reuteri</i> DSM 17938 and Agave Inulin in Children with Cerebral Palsy and Chronic Constipation: A Double-Blind Randomized Placebo Controlled Clinical Trial.

Nutrients·2020
Same author

Factors associated with the stool characteristics of children with cerebral palsy and chronic constipation.

Revista espanola de enfermedades digestivas·2019
Same author

[Anthropometric measures and their relationship with the polymorphism G-2548A of the LEP gene in obese women from Mexico].

Salud publica de Mexico·2018
Same author

[Assessment of in vitro immune response in a young population exposed to atmospheric contamination of Guadalajara].

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)·2009
Same author

Recovery of IFN-gamma levels in PBMCs from lepromatous leprosy patients through the synergistic actions of the cytokines IL-12 and IL-18.

International immunopharmacology·2008

Leprosy likely arrived in Mexico 12,000 years ago, not with European conquerors. While controlled, ongoing monitoring is crucial to interrupt transmission and eliminate this public health concern.

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • Leprosy (Hansen's disease) has a complex history in Mexico, with current research suggesting ancient Asian migration as the origin.
  • Disease registration has occurred since the colonial era, and it was a significant public health issue until 2004.

Observation:

  • Mexico achieved a leprosy incidence below 1 per 10,000 by 2004, meeting World Health Organization (WHO) targets.
  • Despite national control, 49 prefectures exhibit higher-than-average prevalence.
  • Leprosy incidence has not shown consistent reduction in the past decade, indicating an interrupted transmission cycle.

Findings:

  • Current epidemiological data suggests leprosy remains endemic in specific regions of Mexico.
  • The infection cycle of leprosy persists, despite overall national control measures.

Related Experiment Videos

Implications:

  • Continued epidemiological surveillance and active case-finding are essential for leprosy elimination in Mexico.
  • Targeted interventions in high-prevalence areas are necessary to address persistent transmission.
  • Understanding the ancient origins of leprosy in Mexico provides historical context for current public health strategies.